EWG vs IBB
iShares MSCI Germany ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.49% for EWG.
- • EWG pays a higher dividend yield (2.01%).
Side-by-side metrics
| Metric | EWG | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.44% |
Dividend yield Trailing 12-month yield. | 2.01% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $1.58B | $9.09B |
YTD return | -0.87% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 0.69 |
P/E ratio | 17.59 | 24.79 |
Last price | $41.60 | $196.62 |
Inception | — | — |
Issuer | iShares | iShares |
EWG top holdings
| SIE.DE | Siemens AG | 12.63% |
| ALV.DE | Allianz SE | 9.53% |
| SAP.DE | SAP SE | 8.46% |
| ENR.DE | Siemens Energy AG Ordinary Shares | 7.77% |
| IFX.DE | Infineon Technologies AG | 6.45% |
| DTE.DE | Deutsche Telekom AG | 4.95% |
| MUV2.DE | Munchener Ruckversicherungs-Gesellschaft AG | 3.86% |
| DBK.DE | Deutsche Bank AG | 3.25% |
| DHL.DE | Deutsche Post AG | 2.95% |
| BAYN.DE | Bayer AG | 2.88% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About EWG
EWG (iShares MSCI Germany ETF) is German large and mid-cap equities. Managed by iShares, the fund carries $1.6B in assets under management, an expense ratio of 0.49%, a dividend yield of 2.01%. Its largest holding is Siemens AG (SIE.DE), which represents 12.6% of the portfolio. Real Estate is the fund's largest sector exposure at 0.9%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.